Skip To Content

ACD/Labs Blog

The release expands format agnostic capabilities and provides dedicated tools to help scientists make faster decisions with assembled multi-technique analytical data, and delivers new functionality for NMR spectroscopists and mass spectrometrists. Toronto, CANADA (November 22, 2022)—ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced the release of version 2022...

AI-assisted drug discovery is all the rage these days. It seems as if new companies and partnerships are being announced every day. Is this a new phenomenon, or an evolution of what has been done in the past? What are the key challenges standing in the way of computer-assisted drug discovery? For the last episode...

Product safety is critical in the chemical and pharmaceutical industries. Everyone needs to trust the medication they take, the food they eat, and the personal care products they use. Unfortunately, this has required the use of animal testing, which has been a controversial subject for decades. Thanks to scientific advancements, the age of animal testing...

Computational chemistry tools are becoming more powerful every day. Machine learning, artificial intelligence, big data… what does it all mean and how does it apply to the chemistry lab? Season 2 of the Analytical Wavelength explores how predictive technology is shaping the future of science. In this episode, we explore the fundamentals of machine learning,...

This guide to informatics and data integrity published by the European Pharmaceutical Review highlights ACD/Labs software solutions including our Spectrus and Percepta platforms, and new solutions Luminata and Katalysts D2D.